comparemela.com

Latest Breaking News On - Cell therapeutics - Page 6 : comparemela.com

OpRegen® (RG6501) Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit

BCVA gains of +5.5 letters at 24 months in Cohort 4 patients BCVA gains of +7.4 letters among Cohort 4 patients with extensive OpRegen bleb coverage of the GA lesion Maintenance or increases.

Israel
Jerusalem
Israel-general
United-states
American
David-telander
Brianm-culley
Roche-group
Genentech
Foundation-fighting-blindness
Exchange-commission
Oregon-health-science-university-casey-eye-institute

Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM)

Award Will Support 2nd Annual Spinal Cord Injury Investor Symposium To Be Held June 26 and 27, 2024 .

California
United-states
Miami
Florida
American
Jerod-hanna-nieder
Marco-baptista
Brianm-culley
Richardg-fessler
Jack-allen
Steven-kirshblum
Joseph-pantginis

Lineage Cell Therapeutics : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 11, 2024, PROXY

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Schedule 14A Information .

San-diego
California
United-states
San-francisco
London
City-of
United-kingdom
San-bernardino
University-of-california-irvine
Buckinghamshire
Cambridge
Cambridgeshire

Lineage Cell Therapeutics : Additional proxy soliciting materials - definitive

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Schedule 14A Information .

United-states
Washington
Lineage-cell-therapeutics-inc
Exchange-act
Securities-exchange
Statement-pursuant
Securities-exchange-act
Commission-only
Material-pursuant
Cell-therapeutics
Its-charter

Lineage Announces Changes to Board of Directors

Lineage Cell Therapeutics, Inc. is saddened to report the passing of its long-serving Chairman of the Board of Directors, Mr. Alfred D. Kingsley, and offers its deepest condolences to Mr..

California
United-states
American
Michaelh-mulroy
Alfredd-kingsley
Los-angeles
Financial-strategy-committee
Senior-advisor-to-camberview-partners
Audit-committee
Company-board-of-directors
Strategic-affairs
Genentech

vimarsana © 2020. All Rights Reserved.